Whitepaper

#Eurofins #GPCR #Whitepaper

Whitepaper: Improving the predictive power of GPCR assays

How much of your compound’s activity are your assays really detecting? Understanding how receptor density impacts pharmacological responses is critical for accurately characterising compound activity & identifying candidates with the highest likelihood of therapeutic success. Explore this whitepaper by GPCR expert Terry Kenakin, PhD, and EurofinsDiscoverX to… Read More

#News

Vaccine research
#Contract Research Organisations (CROs) #Drug discovery #Preclinical development #Whitepaper

Whitepaper: How important is onshoring preclinical research?

This Whitepaper by Crown Bioscience outlines the onshoring strategies for pharmaceutical companies and how this affects decisions to work with contract research organisations (CRO) at home or abroad. Readers will learn: The regulatory developments driving onshoring strategies Industry considerations for choosing a CRO When onshoring needs to be considered Download… Read More

#Editor's Choice #News

mRNA
#In vitro #mRNA #Whitepaper

Whitepaper: Explore a new approach to IVT capping

Download this new Whitepaper from Aldevron to learn about a novel RNA polymerase designed to support high-quality mRNA production. Supports co-transcriptional capping during in vitro transcription (IVT) Designed to work efficiently with commercially available cap analogs Helps researchers generate high-quality mRNA transcripts Access the full Whitepaper to explore IVT capping… Read More

#News

T cell engagers
#Cell Science #Drug discovery #T cell engagers #Whitepaper

Whitepaper – T-cell engagers: From drug discovery hurdles to next-gen solutions

Read this new Whitepaper from WuXi Biologics. Innovative platforms across key stages of TCE drug discovery, with real-world case studies on high-purity production and fit-for-purpose in vitro & in vivo studies. Proven approaches to navigate key development challenges, such as structural complexity, CRS risks, and tumour heterogeneity. Forward-looking strategies combining… Read More

#News

New drug application
#ADME / Tox #Drug discovery #Regulatory #Whitepaper

Whitepaper: Secure your place in the IND race

A new exclusive whitepaper is now available from Lonza entitled ‘Secure your place in the IND race with a rapid tox approach‘. Early tox material can offer valuable clarity as programmes progress toward IND. Lonza’s latest whitepaper introduces a new offering that helps drug developers shorten timelines and generate… Read More

#News

Bispecific antibodies
#Bispecific Antibodies #Cell line development #Whitepaper

A practical guide to robust bispecific antibody cell line development

In this new whitepaper, discover how ProBio accelerates bispecific antibody development with optimised cell line strategies. This guide highlights proven methods such as two-vector expression systems and NGS‑enabled clone selection to improve purity, productivity, and manufacturing robustness. You will learn: How to reduce bispecific antibody impurities through chain‑ratio optimisation Methods… Read More

#News

#Drug development #Drug discovery #Regulatory #Whitepaper

Whitepaper: Learn how to comply with mandatory USP revision

A new whitepaper from Mettler Toledo is available for free download entitled ‘Ensure Compliance with US Pharmacopeia’. Key highlights: Comprehensive explanation of the newly revised USP General Chapters 41 and 1251 Practical advice on how to implement these revised requirements effectively Guidance to help ensure compliance with updated USP weighing… Read More

#News

amino acids chain
#Drug development #Drug discovery #Live cell analysis #Protein degradation #Whitepaper

Whitepaper: See what’s driving the next wave of degrader discovery

The kinetic profile of degrader compounds is critical to optimised design, showing how live-cell kinetic analysis transforms discovery. A new Whitepaper from Promega entitled ‘Beyond Endpoints: Capturing and Translating The Dynamics of Targeted Protein Degradation‘ reveals how tracking protein dynamics in live cells delivers richer, more actionable data to… Read More

#News

#Drug development #Drug discovery #Live cell analysis #Protein degradation #Whitepaper

See what’s driving the next wave of degrader discovery

The kinetic profile of degrader compounds is critical to optimised design, showing how live-cell kinetic analysis transforms discovery. This Whitepaper reveals how tracking protein dynamics in live cells delivers richer, more actionable data to improve compound optimisation across programmes. The Whitepaper will discuss: Why kinetic data deliver deeper context than… Read More

#Resources #Whitepapers

Human brain
#Biomarkers #Drug discovery #Neurology #Neuroscience #Whitepaper

Navigating neurological biomarker research: Download the Whitepaper

Neurological biomarker research is advancing rapidly, but key challenges remain. Download this new Whitepaper from Olink entitled ‘Navigating neurological biomarker research: Progress, learnings and future directions’. The Whitepaper captures: Expert perspectives from academia and biopharma Highlighting successes, setbacks, and strategies for translational advancements in Alzheimer’s, Parkinson’s, and MS. A… Read More

#News

#Biomarkers #Drug discovery #Neurology #Neuroscience #Whitepaper

Navigating neurological biomarker research: Progress, learnings and future directions

Neurological biomarker research is advancing rapidly, but key challenges remain. This Whitepaper captures: Expert perspectives from academia and biopharma Highlighting successes, setbacks, and strategies for translational advancements in Alzheimer’s, Parkinson’s, and MS. A must-read for researchers navigating the future of precision neurology. Read More

#Resources #Whitepapers

#Drug discovery #Multi-omics #Omics #Whitepaper

Accelerating pharma innovation with 5D multiomics – download now

Today’s drug discovery teams face increasing pressure to accelerate timelines, improve translational success, and minimise costly clinical failures. Yet most platforms still rely on fragmented technologies that deliver partial or delayed insights—forcing you to reconstruct biology from disconnected data. A new Whitepaper from Element Biosciences discusses the AVITI24 5D multiomics… Read More

#News

#Drug discovery #Multi-omics #Omics #Whitepaper

Accelerating pharma innovation and drug discovery with 5D multiomics

Today’s drug discovery teams face increasing pressure to accelerate timelines, improve translational success, and minimise costly clinical failures. Yet most platforms still rely on fragmented technologies that deliver partial or delayed insights—forcing you to reconstruct biology from disconnected data. AVITI24™ 5D multiomics platform offers a new path by capturing RNA,… Read More

#Resources

Tumour microenvironment
#Cancer #Drug development #Tumour microenvironment (TME) #Whitepaper

Whitepaper: How protein biomarkers can impact cancer outcomes

Download this whitepaper by Standard BioTools to learn about the tumour microenvironment (TME) and the protein biomarkers helping to shape cancer outcomes. The tumour microenvironment (TME) is no longer considered a passive backdrop to cancer. It is a dynamic ecosystem that plays a central role in tumour growth, immune suppression,… Read More

#News

#Biomarkers #Oncology #Whitepaper

Learn about protein biomarkers shaping cancer outcomes in the tumour microenvironment

The tumour microenvironment (TME) is no longer considered a passive backdrop to cancer. It is a dynamic ecosystem that plays a central role in tumour growth, immune suppression, metastasis and treatment resistance. Whitepaper highlights: Understand how the TME drives cancer progression, immune evasion and therapeutic resistance Explore emerging strategies that… Read More

#Resources